Division of Urology, The Hospital for Sick Children, Toronto, ON, Canada.
Institute of Urology, St. Luke's Medical Center, QC, NCR, Quezon City, Philippines.
BJU Int. 2021 Jun;127(6):687-702. doi: 10.1111/bju.15264. Epub 2020 Nov 13.
To determine differences in perioperative outcomes between retroperitoneal and transperitoneal approaches for laparoscopic pyeloplasty (LP) to manage pelvi-ureteric junction obstruction (PUJO) through a meta-analysis of comparative studies.
A systematic search was performed in January 2020. Comparative studies were evaluated according to Cochrane Collaboration recommendations. Assessed outcomes included success and complication rates, conversion to open surgery, operative time (OT), length of hospital stay (LOS), estimated blood loss (EBL), analgesic requirements, regular diet resumption, and drain duration. Relative risk (RR) and standardised mean difference (SMD) with 95% confidence intervals (CIs) were extrapolated. Subgroup analyses were performed according to study design and techniques. International Prospective Register of Systematic Reviews (PROSPERO) number: CRD42020163303.
A total of 18 studies describing 2007 cases were included. Overall pooled effect estimates did not show statistically significant differences between the approaches with regards to success rate (RR 0.99; 95% CI 0.97, 1.01), complications (RR 1.09; 95% CI 0.82, 1.45), OT (SMD 0.61; 95% CI -0.04, 1.26), LOS (SMD -0.30; 95% CI -0.63, 0.04), EBL (SMD -0.53; 95% CI -1.26, 0.21), or analgesic requirements (SMD -0.51; 95% CI -1.23, 0.21). Compared to the transperitoneal approach, retroperitoneal LP had a higher conversion rate (RR 2.40; 95% CI 1.23, 4.66); however, patients resumed diets earlier (SMD -2.49; 95% CI -4.17, -0.82) and had shorter drain duration (SMD -0.31; 95% CI -0.57, -0.05).
The evidence suggests that there are no significant differences in success rate, OT and complications between transperitoneal and retroperitoneal LP. Conversion rates are higher with the retroperitoneal approach; however, return to diet occurs faster and drain duration is shorter when compared to the transperitoneal approach.
通过对比较研究的荟萃分析,确定后腹腔镜肾盂成形术(LP)治疗肾盂输尿管连接部梗阻(PUJO)的腹膜后和经腹腔途径在围手术期结果方面的差异。
2020 年 1 月进行了系统检索。根据 Cochrane 协作组的建议评估了比较研究。评估的结果包括成功率和并发症发生率、转为开放手术、手术时间(OT)、住院时间(LOS)、估计失血量(EBL)、镇痛需求、恢复常规饮食、引流时间。提取了相对风险(RR)和标准化均数差(SMD)及 95%置信区间(CI)。根据研究设计和技术进行了亚组分析。国际前瞻性系统评价注册中心(PROSPERO)编号:CRD42020163303。
共纳入 18 项研究,描述了 2007 例病例。总体汇总效应估计表明,两种方法在成功率(RR 0.99;95%CI 0.97,1.01)、并发症(RR 1.09;95%CI 0.82,1.45)、OT(SMD 0.61;95%CI -0.04,1.26)、LOS(SMD -0.30;95%CI -0.63,0.04)、EBL(SMD -0.53;95%CI -1.26,0.21)或镇痛需求(SMD -0.51;95%CI -1.23,0.21)方面无统计学差异。与经腹腔途径相比,腹膜后 LP 具有更高的转化率(RR 2.40;95%CI 1.23,4.66);然而,患者更早恢复饮食(SMD -2.49;95%CI -4.17,-0.82)且引流时间更短(SMD -0.31;95%CI -0.57,-0.05)。
证据表明,经腹腔和腹膜后 LP 在成功率、OT 和并发症方面无显著差异。腹膜后入路的转化率较高;然而,与经腹腔入路相比,恢复饮食更快,引流时间更短。